The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

NCT06254521 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
Rectal Cancer Stage II
Rectal Cancer Stage III

Interventions

DRUG: Tislelizumab combined with chemotherapy

Sponsor

First Affiliated Hospital of Guangxi Medical University